ImmunisLogoWImmunisLogocropped-immunislogo.pngcropped-immunislogo.png
  • Home
  • About Us
    • Mission
    • Technology
    • Leadership
    • FAQs
  • Overview
    • Pipeline
    • STEM-MYO Program
      • Phase 1/2a Clinical Trial
    • STEM-META Program
      • Phase 2 Clinical Trial
  • News
    • Awards
    • Features
    • Press Releases
  • Contact
✕
  • Home
  • Awards

2025

2024

2023

2022

2021

Recent News

  • May 12, 2025

    Immunis Named a Semifinalist in the $101 Million XPRIZE Healthspan Competition

  • Mar 4, 2025

    Immunis Treats its First Patients for Sarcopenic Obesity

  • Jan 11, 2025

    Immunis Closes $25 Million Series A-1 Financing Round

Navigation

  • Home
  • About Us
    • Mission
    • Technology
    • Leadership
    • FAQs
  • Overview
    • Pipeline
    • STEM-MYO Program
      • Phase 1/2a Clinical Trial
    • STEM-META Program
      • Phase 2 Clinical Trial
  • News
    • Awards
    • Features
    • Press Releases
  • Contact

Contact info

Immunis, Inc.
Irvine, California


contact@immunisbiomedical.com

Copyright © 2025 Immunis, Inc.